InvestorNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Announces Blitz Campaign to Educate Public about Direct-to-Consumer Hearing Loss Treatment Options

July 19, 2021 10:55 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer hearing health technology space, has partnered with “New to the Street TV” to produce, broadcast and distribute commercials and digital billboards for INND’s Hearing Loss Media Blitz campaign. The commercials and billboards will focus on hearing loss awareness and INND’s direct-to-consumer, Bluetooth-controlled, self-adjusting, rechargeable hearing aids. The company’s hearing aids are a viable solution for the 48 million Americans who have hearing loss, and INND will use the commercials and digital billboards to educate the public about hearing loss and the need for early treatment. The partnership will include a minimum of 660 commercials, 110 per month for the next six months, which will appear on Fox News, Bloomberg, Fox Business Network, CNN, CNBS, Newsmax TV and MSNB. In addition, the contract calls for 156 digital billboards to appear throughout lower Manhattan in New York. InnerScope will also use content from the campaign on its website and social media channels. INND also intends to release additional multimedia marketing campaigns this year. The campaigns will feature the company’s new flexible subscription plans. Through these efforts, the company is hoping to empower consumers to take control of their hearing issues. “The launch of our Hearing Loss Media Blitz campaign could not have come at a better time, especially after last week’s executive order from President Biden and his remarks on making hearing aids more affordable and able to be sold over the counter in pharmacies without any medical evaluation,” said InnerScope Hearing Technology CEO Matthew Moore in the press release. “Unfortunately, the public is not aware that direct-to-consumer hearing aids have been available to purchase online without any medical evaluation needed. InnerScope has its affordable direct-to-consumer hearing aids available through its MyHearIQ.com online store for consumers to purchase today. The partnership we have with ‘New to the Street’ and their sophisticated media production staff and writers has resulted in a fantastic platform to get the message out. We are confident our Hearing Loss Media Blitz Campaign will establish InnerScope as the leader in providing direct-to-consumer Bluetooth app-controlled self-adjusting rechargeable hearing aids, shipped directly to the consumer, as an affordable hearing loss treatment solution.”

To view the full press release, visit https://ibn.fm/t5Fuw

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer, distributor and retailer of FDA-registered, direct-to-consumer (“DTC”), Bluetooth-controlled hearing aids; Bluetooth-controlled, self-adjusting personal sound amplifier products; hearing-related treatment therapies; doctor-formulated dietary hearing and tinnitus supplements; and other hearing and health-related products targeting tens of millions Americans suffering from hearing related problems. The company’s mission is to improve the quality of life for the tens of millions of people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and hearing-related issues. INND’s management team is applying decades of industry experience and believes the company is well positioned with its affordable Bluetooth-controlled, self-adjusting hearing technoloty and it innovative, in-store sales and delivery system with its point-of-sale free self-check hearing screening kiosks to directly benefit when the Over-the-Counter Hearing Aid Act becomes enacted. The OTC Hearing Aid Law allows OTC hearing aids for perceived mild-to-moderate hearing losses to be sold in retail stores without seeing a professional or having a medical evaluation. The Hearing Kiosk is designed for the tens of millions of Americans with undetected or untreated mild-to-moderate hearing losses to treat themselves with the company’s easy, convenient and affordable OTC hearing aids in-store, off the shelf or by DTC online affordable hearing-aid options. For more information, please visit www.INND.com.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Investor Brand Network, Press Releases

Related Entities

FDA